Il-17 antagonistic antibodies fpr treating cancer
作者： Michael Cooreman , Padova Franco E. Di
DOI:
关键词: Hypervariable region 、 Amino acid 、 Interleukin 17 、 Immunoglobulin light chain 、 Biology 、 Cancer 、 Antibody 、 Molecular biology
摘要: An IL-17 binding molecule, in particular an antibody to human IL-17, more preferably a is provided, wherein the hypervariable regions of heavy and light chains have amino acid sequences as defined, for use treatment solid or hematological malignant diseases.
glgoo.top参考文章(5)
M. Numasaki, Interleukin-17 promotes angiogenesis and tumor growth. Blood. ,vol. 101, pp. 2620- 2627 ,(2003) , 10.1182/BLOOD-2002-05-1461
Francis J Dumont, IL-17 cytokine/receptor families: emerging targets for the modulation of inflammatory responses Expert Opinion on Therapeutic Patents. ,vol. 13, pp. 287- 303 ,(2003) , 10.1517/13543776.13.3.287
Jean-Michel Rene Rondeau, Hermann Gram, Margit Jeschke, Franco E. Di Padova, Hans Hofstetter, Wim Van Den Berg, IL-17 antagonistic antibodies ,(2005)
Simon Peter Ucb Celltech Tickle, Ralph Ucb Celltech Adams, Andrew George Ucb Celltech Popplewell, Stephen Edward Ucb Celltech Rapecki, Neutralising antibody molecules having specificity for human IL-17 ,(2005)
Jacques Banchereau, Serge J. E. Lebecque, Hervé Fridman, François Fossiez, Eric Tartour, Compositions and methods for treating cell proliferation disorders ,(2000)